Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Phio Pharmaceuticals Corp.

NASDAQ: PHIO · Life Sciences · 8 alerts · CIK 1533040

Share price
$0.7522Close, Nov 16
Market cap
$8.99M
Shares outstanding
11.95MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Phio Pharmaceuticals Corp. filings on SEC EDGAR ↗

8:42 AM ET 8-K
Business Update

Phio Pharmaceuticals Business Update

Phio Pharmaceuticals successfully completed its first commercial-scale cGMP batch of PH-762 drug substance, a key manufacturing milestone. This achievement validates the company's supply chain readiness and supports the planned initiation of a Phase 2b clinical trial in the first quarter of 2027.

9:00 AM ET 8-K
Business Update

Phio Pharmaceuticals Business Update

Phio Pharmaceuticals has submitted a meeting request and comprehensive briefing package to the FDA to support the next stage of clinical development for its lead candidate, PH-762. The submission follows the completion of a Phase 1b trial and outlines a proposed Phase 2b neoadjuvant study in cutaneous squamous cell carcinoma.

Counterparty
FDA

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.